Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
STNeuronetics, Inc. logo

Neuronetics, Inc. (STIM)

NASDAQ Global Market · Currency in USD
$2.11 ▲ +0.03 (+1.44%)
At close: Oct 23, 4:00 PM ET. Market closed.
$2.11 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$2.08
Open
$2.09
Day's Range
$2.02 – $2.18
52 Week Range
$0.80 – $3.44
Volume
600,333
Avg. Volume
1,790,814
Market Cap
$160.78M
Beta (5Y Monthly)
1.20
PE Ratio (TTM)
--
EPS (TTM)
-$0.43
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$5.00

Profile: Neuronetics, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
658
CEO
Daniel L. Reuvers

Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate -$0.08 · Revenue est. $40.43M
DateEst.Actual
Aug 11, 2026-$0.12-$0.05Beat
May 5, 2026-$0.17-$0.16Beat
Mar 17, 2026-$0.12-$0.10Beat
Nov 4, 2025-$0.12-$0.13Miss
Aug 5, 2025-$0.08-$0.15Miss
May 6, 2025-$0.13-$0.21Miss

Analyst view

Consensus price target
$5.00 ▲ +137.0%
Range $5.00 – $5.00
Rating: Buy
Buy 86% · Hold 14% · Sell 0%

Get free alerts on STIM and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.